Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03823144 · ClinicalTrials.gov registry record · NA

Intravital Microscopy in Human Solid Tumors

A NA study of Malignant Solid Neoplasm and Solid Tumor, Adult, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT03823144 is a NA study of Malignant Solid Neoplasm and Solid Tumor, Adult that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 85 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03823144, a NA study of Malignant Solid Neoplasm and Solid Tumor, Adult, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microscopy (IVM) in order to visualize in real-time the vessels associated with solid tumors. The IVM observations may determine if an individual patient's tumor vessels would be amenable to receiving systemic therapy, based on the functionality of the vessels.

Interventions

  • DEVICE Diagnostic Microscopy
  • DRUG Fluorescein Sodium Injection

Study Locations (1)

Florida

  • Mayo Clinic Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2019-02-28
Est. Completion 2026-09-30
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03823144

The ClinicalTrials.gov registry entry for NCT03823144 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (93% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Diagnostic Microscopy is the first listed.

NCT03823144 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03823144 about?

NCT03823144 is a clinical study titled "Intravital Microscopy in Human Solid Tumors". This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microscopy (IVM) in order to visualize in real-time the vessels associated with solid tumors. The IVM observations may determine if an individual pa...

What is the current status of trial NCT03823144?

This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2019-02-28. Estimated completion is 2026-09-30.

What conditions does trial NCT03823144 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Solid Tumor, Adult, Metastatic Colorectal Carcinoma, Clinical Stage IV Gastric Cancer AJCC v8, Metastatic Sarcoma.

What interventions are being tested in trial NCT03823144?

The interventions under investigation include: Diagnostic Microscopy (DEVICE), Fluorescein Sodium Injection (DRUG).

Who is sponsoring clinical trial NCT03823144?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03823144 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.